share_log

RBC Capital Initiates Coverage On Applied Therapeutics With Outperform Rating, Announces Price Target of $12

Benzinga ·  Mar 26 08:53

RBC Capital analyst Brian Abrahams initiates coverage on Applied Therapeutics (NASDAQ:APLT) with a Outperform rating and announces Price Target of $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment